SECCHI, O.; FRANCHI, A.; LUNELLO, A. Comments to “Cost per responder for vedolizumab and ustekinumab in Crohn’s disease patients after failure of TNF-α inhibitors in Italy”. AboutOpen, [S. l.], v. 10, n. 1, p. 82–86, 2023. DOI: 10.33393/ao.2023.2600. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2600. Acesso em: 3 jul. 2024.